86R7067 CW-D
 
  By: Davis of Harris H.R. No. 161
 
 
 
R E S O L U T I O N
         WHEREAS, Dr. James P. Allison, chair of the department of
  immunology at The University of Texas MD Anderson Cancer Center in
  Houston, was awarded the 2018 Nobel Prize in Physiology or
  Medicine; and
         WHEREAS, A world-renowned scientist and pioneer in cancer
  immunotherapy, Dr. Allison received the award jointly with
  Japanese immunologist Tasuku Honjo for their independent discovery
  of cancer therapies that stimulate the immune system to attack
  tumor cells; during Dr. Allison's research of T cells, white blood
  cells that regulate a wide range of immune responses, he found that
  deactivating the protein CTLA-4 can unleash the body's power to
  fight back against malignant tumors; and
         WHEREAS, Dr. Allison earned his doctoral degree at The
  University of Texas at Austin; the executive director of the
  Immunotherapy Platform at MD Anderson Cancer Center, he is also the
  center's Vivian L. Smith Distinguished Chair in Immunology and the
  director of the Parker Institute for Cancer Immunotherapy; among
  his myriad honors, he is a member of the National Academies of
  Science and Medicine, and he was recognized with the Lasker-Debakey
  Clinical Medical Research Award in 2015; and
         WHEREAS, The groundbreaking contributions of Dr. James
  Allison have placed him at the forefront of a promising new field of
  cancer research, and his efforts are inspiring other scientists in
  the Lone Star State and beyond; now, therefore, be it
         RESOLVED, That the House of Representatives of the 86th Texas
  Legislature hereby congratulate Dr. James P. Allison on his receipt
  of the 2018 Nobel Prize in Physiology or Medicine and extend to him
  sincere best wishes for continued success with his important work;
  and, be it further
         RESOLVED, That an official copy of this resolution be
  prepared for Dr. Allison as an expression of high regard by the
  Texas House of Representatives.